regulatory
confidence high
sentiment negative
materiality 0.80
vTv Therapeutics Inc. (VTVT): Nasdaq/NYSE listing notice — vTv Therapeutics receives Nasdaq delisting notice for MVLS non-compliance
vTv Therapeutics Inc.
- Nasdaq notified vTv on Dec 13, 2023 that MVLS was below $35M for 30 consecutive business days.
- Company has 180 calendar days, until June 10, 2024, to regain compliance.
- To regain compliance, MVLS must close at $35M or more for 10 consecutive business days.
- Failure to cure may result in delisting of Class A common stock from Nasdaq Capital Market.
- Company is evaluating options but offers no assurance of regaining compliance.